The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis

od W Rogowski, J Burch, S Palmer, C Craigs, S Golder, N Woolacott
Wydane 2009-06-01

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6–11 years

od S Walker, J Burch, C McKenna, K Wright, S Griffin, N Woolacott
Wydane 2011-05-01

Are adverse effects incorporated in economic models? An initial review of current practice

od D Craig, C McDaid, T Fonseca, C Stock, S Duffy, N Woolacott
Wydane 2009-12-01

Rimonabant for the treatment of overweight and obese people

od J Burch, C McKenna, S Palmer, G Norman, J Glanville, M Sculpher, N Woolacott
Wydane 2009-10-01

Alitretinoin for the treatment of severe chronic hand eczema

od M Paulden, M Rodgers, S Griffin, R Slack, S Duffy, JR Ingram, N Woolacott, M Sculpher
Wydane 2010-05-01

Dronedarone for the treatment of atrial fibrillation and atrial flutter

od E Maund, C McKenna, M Sarowar, D Fox, M Stevenson, C Pepper, S Palmer, N Woolacott
Wydane 2010-10-01

The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic...

od J Burch, S Hinde, S Palmer, F Beyer, J Minton, A Marson, U Wieshmann, N Woolacott, M Soares
Wydane 2012-09-01

Golimumab for the treatment of psoriatic arthritis

od H Yang, D Epstein, L Bojke, D Craig, K Light, I Bruce, M Sculpher, N Woolacott
Wydane 2011-05-01

Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation

od M Rodgers, C McKenna, S Palmer, D Chambers, S Van Hout, S Golder, C Pepper, D Todd, N Woolacott
Wydane 2008-11-01

EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation

od C McKenna, R Wade, R Faria, H Yang, L Stirk, N Gummerson, M Sculpher, N Woolacott
Wydane 2012-03-01

Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model

od D Chambers, D Epstein, S Walker, D Fayter, F Paton, K Wright, J Michaels, S Thomas, M Sculpher, N Woolacott
Wydane 2009-10-01

Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment

od D Chambers, M Paulden, F Paton, M Heirs, S Duffy, D Craig, J Hunter, J Wilson, M Sculpher, N Woolacott
Wydane 2010-07-01

Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation

od G Norman, R Faria, F Paton, A Llewellyn, D Fox, S Palmer, I Clifton, J Paton, N Woolacott, C McKenna
Wydane 2013-11-01

Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis

od C McKenna, C McDaid, S Suekarran, N Hawkins, K Claxton, K Light, M Chester, J Cleland, N Woolacott, M Sculpher
Wydane 2009-04-01

A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure

od C McKenna, J Burch, S Suekarran, S Walker, A Bakhai, K Witte, M Harden, K Wright, N Woolacott, P Lorgelly, L Fenwick, S Palmer
Wydane 2010-05-01

Etanercept and efalizumab for the treatment of psoriasis: a systematic review

od N Woolacott, N Hawkins, A Mason, A Kainth, Z Khadjesari, Y Bravo Vergel, K Misso, K Light, R Chalmers, M Sculpher, R Riemsma
Wydane 2006-11-01

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation

od M Rodgers, D Epstein, L Bojke, H Yang, D Craig, T Fonseca, L Myers, I Bruce, R Chalmers, S Bujkiewicz, M Lai, N Cooper, K Abrams, D Spiegelhalter, A Sutton, M Sculpher, N Woolacott
Wydane 2011-02-01